|
Post by mango on Dec 13, 2020 20:34:12 GMT -5
Saw this on ST. The website is janky but it looks legit. TYVASO DPI TREPROSTINIL INHALATION POWDERMark For: TYVASO DPI TREPROSTINIL INHALATION POWDER™ trademark registration is intended to cover the categories of pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension and interstitial lung disease, and idiopathic pulmonary fibrosis. uspto.report/TM/90370409
|
|
|
Post by buyitonsale on Dec 13, 2020 20:47:29 GMT -5
I am guessing that UTHR will be using the word "Tyvaso" for the NDA submission.
I think it's a good idea to continue with Tyvaso franchise and the name recognition, it will make switching patients to the new DPI device easier.
|
|
|
Post by mango on Dec 13, 2020 21:17:57 GMT -5
I am guessing that UTHR will be using the word "Tyvaso" for the NDA submission. I think it's a good idea to continue with Tyvaso franchise and the name recognition, it will make switching patients to the new DPI device easier. I agree.
|
|